Implant stability in patients treated with platelet‐rich fibrin and bovine bone substitute for alveolar ridge preservation is associated with peripheral blood cells and coagulation factors

Abstract Aims The aim of the present study was to assess the association between dental implant stability and peripheral blood cell composition and levels of coagulation factors in patients treated with alveolar ridge preservation with platelet‐rich fibrin (PRF) and bovine bone substitute. Materials...

Full description

Bibliographic Details
Main Authors: Joost E.I.G. Brouwers, Lisa N. van derVorm, Sharon Buis, Rianne Haumann, Avesta Karanzai, Joke Konings, Philip G. deGroot, Bas deLaat, Jasper A. Remijn
Format: Article
Language:English
Published: Wiley 2020-04-01
Series:Clinical and Experimental Dental Research
Subjects:
Online Access:https://doi.org/10.1002/cre2.263
id doaj-d43f569e9105487b9e1952e6700ee689
record_format Article
spelling doaj-d43f569e9105487b9e1952e6700ee6892020-11-25T03:23:45ZengWileyClinical and Experimental Dental Research2057-43472020-04-016223624310.1002/cre2.263Implant stability in patients treated with platelet‐rich fibrin and bovine bone substitute for alveolar ridge preservation is associated with peripheral blood cells and coagulation factorsJoost E.I.G. Brouwers0Lisa N. van derVorm1Sharon Buis2Rianne Haumann3Avesta Karanzai4Joke Konings5Philip G. deGroot6Bas deLaat7Jasper A. Remijn8Institute for Dental Implantology Amersfoort The NetherlandsDepartment of Clinical Chemistry and Hematology Gelre Hospitals Apeldoorn The NetherlandsInstitute for Dental Implantology Amersfoort The NetherlandsDepartment of Clinical Chemistry and Hematology Gelre Hospitals Apeldoorn The NetherlandsInstitute for Dental Implantology Amersfoort The NetherlandsSynapse Research Institute Maastricht The NetherlandsSynapse Research Institute Maastricht The NetherlandsDepartment of Clinical Chemistry and Hematology Gelre Hospitals Apeldoorn The NetherlandsDepartment of Clinical Chemistry and Hematology Gelre Hospitals Apeldoorn The NetherlandsAbstract Aims The aim of the present study was to assess the association between dental implant stability and peripheral blood cell composition and levels of coagulation factors in patients treated with alveolar ridge preservation with platelet‐rich fibrin (PRF) and bovine bone substitute. Materials and methods Fifty patients were included between 2015 and 2017. PRF was prepared from autologous blood, in which blood cells and coagulation factor levels were measured. PRF and bovine bone were placed in the socket, followed by closure with PRF membrane. Implants were placed 14 (±2.5) weeks postextraction. The implant stability quotient was measured at t = 0, t = 10 days, t = 7 weeks, and t = 17 weeks by resonance frequency analysis. Results Erythrocyte count was inversely associated with PRF membrane length, but not with implant stability. Conversely, platelet count did not correlate with membrane size but inversely correlated with implant stability at 7 and 17 weeks. In addition, implant stability was directly correlated with levels FXIII (t = 0, p < .01), active von Willebrand factor (VWF; t = 0 and 7 weeks, p < .05), and total VWF (t = 7 weeks, p = .012). Conclusion Implant stability following alveolar ridge preservation with PRF and bovine bone substitute is associated with circulating blood cells and coagulation factors. In particular, fibrin structure, VWF, and FXIII may be important modulators of implant stability.https://doi.org/10.1002/cre2.263alveolar ridge preservationblood cellsblood coagulationimplant stabilityplatelet‐rich fibrin
collection DOAJ
language English
format Article
sources DOAJ
author Joost E.I.G. Brouwers
Lisa N. van derVorm
Sharon Buis
Rianne Haumann
Avesta Karanzai
Joke Konings
Philip G. deGroot
Bas deLaat
Jasper A. Remijn
spellingShingle Joost E.I.G. Brouwers
Lisa N. van derVorm
Sharon Buis
Rianne Haumann
Avesta Karanzai
Joke Konings
Philip G. deGroot
Bas deLaat
Jasper A. Remijn
Implant stability in patients treated with platelet‐rich fibrin and bovine bone substitute for alveolar ridge preservation is associated with peripheral blood cells and coagulation factors
Clinical and Experimental Dental Research
alveolar ridge preservation
blood cells
blood coagulation
implant stability
platelet‐rich fibrin
author_facet Joost E.I.G. Brouwers
Lisa N. van derVorm
Sharon Buis
Rianne Haumann
Avesta Karanzai
Joke Konings
Philip G. deGroot
Bas deLaat
Jasper A. Remijn
author_sort Joost E.I.G. Brouwers
title Implant stability in patients treated with platelet‐rich fibrin and bovine bone substitute for alveolar ridge preservation is associated with peripheral blood cells and coagulation factors
title_short Implant stability in patients treated with platelet‐rich fibrin and bovine bone substitute for alveolar ridge preservation is associated with peripheral blood cells and coagulation factors
title_full Implant stability in patients treated with platelet‐rich fibrin and bovine bone substitute for alveolar ridge preservation is associated with peripheral blood cells and coagulation factors
title_fullStr Implant stability in patients treated with platelet‐rich fibrin and bovine bone substitute for alveolar ridge preservation is associated with peripheral blood cells and coagulation factors
title_full_unstemmed Implant stability in patients treated with platelet‐rich fibrin and bovine bone substitute for alveolar ridge preservation is associated with peripheral blood cells and coagulation factors
title_sort implant stability in patients treated with platelet‐rich fibrin and bovine bone substitute for alveolar ridge preservation is associated with peripheral blood cells and coagulation factors
publisher Wiley
series Clinical and Experimental Dental Research
issn 2057-4347
publishDate 2020-04-01
description Abstract Aims The aim of the present study was to assess the association between dental implant stability and peripheral blood cell composition and levels of coagulation factors in patients treated with alveolar ridge preservation with platelet‐rich fibrin (PRF) and bovine bone substitute. Materials and methods Fifty patients were included between 2015 and 2017. PRF was prepared from autologous blood, in which blood cells and coagulation factor levels were measured. PRF and bovine bone were placed in the socket, followed by closure with PRF membrane. Implants were placed 14 (±2.5) weeks postextraction. The implant stability quotient was measured at t = 0, t = 10 days, t = 7 weeks, and t = 17 weeks by resonance frequency analysis. Results Erythrocyte count was inversely associated with PRF membrane length, but not with implant stability. Conversely, platelet count did not correlate with membrane size but inversely correlated with implant stability at 7 and 17 weeks. In addition, implant stability was directly correlated with levels FXIII (t = 0, p < .01), active von Willebrand factor (VWF; t = 0 and 7 weeks, p < .05), and total VWF (t = 7 weeks, p = .012). Conclusion Implant stability following alveolar ridge preservation with PRF and bovine bone substitute is associated with circulating blood cells and coagulation factors. In particular, fibrin structure, VWF, and FXIII may be important modulators of implant stability.
topic alveolar ridge preservation
blood cells
blood coagulation
implant stability
platelet‐rich fibrin
url https://doi.org/10.1002/cre2.263
work_keys_str_mv AT joosteigbrouwers implantstabilityinpatientstreatedwithplateletrichfibrinandbovinebonesubstituteforalveolarridgepreservationisassociatedwithperipheralbloodcellsandcoagulationfactors
AT lisanvandervorm implantstabilityinpatientstreatedwithplateletrichfibrinandbovinebonesubstituteforalveolarridgepreservationisassociatedwithperipheralbloodcellsandcoagulationfactors
AT sharonbuis implantstabilityinpatientstreatedwithplateletrichfibrinandbovinebonesubstituteforalveolarridgepreservationisassociatedwithperipheralbloodcellsandcoagulationfactors
AT riannehaumann implantstabilityinpatientstreatedwithplateletrichfibrinandbovinebonesubstituteforalveolarridgepreservationisassociatedwithperipheralbloodcellsandcoagulationfactors
AT avestakaranzai implantstabilityinpatientstreatedwithplateletrichfibrinandbovinebonesubstituteforalveolarridgepreservationisassociatedwithperipheralbloodcellsandcoagulationfactors
AT jokekonings implantstabilityinpatientstreatedwithplateletrichfibrinandbovinebonesubstituteforalveolarridgepreservationisassociatedwithperipheralbloodcellsandcoagulationfactors
AT philipgdegroot implantstabilityinpatientstreatedwithplateletrichfibrinandbovinebonesubstituteforalveolarridgepreservationisassociatedwithperipheralbloodcellsandcoagulationfactors
AT basdelaat implantstabilityinpatientstreatedwithplateletrichfibrinandbovinebonesubstituteforalveolarridgepreservationisassociatedwithperipheralbloodcellsandcoagulationfactors
AT jasperaremijn implantstabilityinpatientstreatedwithplateletrichfibrinandbovinebonesubstituteforalveolarridgepreservationisassociatedwithperipheralbloodcellsandcoagulationfactors
_version_ 1724604719483060224